Davide Imberti Selected Research

Prothrombin (Factor II)

5/2009

Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Davide Imberti Research Topics

Disease

27	Venous Thromboembolism 01/2020 - 07/2003
22	Hemorrhage 07/2021 - 07/2003
14	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 07/2004
12	Neoplasms (Cancer) 06/2019 - 06/2005
10	Thrombosis (Thrombus) 06/2019 - 05/2009
10	Pulmonary Embolism 10/2018 - 07/2003
9	Atrial Fibrillation 12/2020 - 04/2013
7	Stroke (Strokes) 12/2020 - 06/2014
5	Thromboembolism 10/2018 - 05/2009
3	Ischemic Stroke 12/2020 - 11/2018
2	Embolic Stroke 01/2019 - 08/2015
2	Thrombocytopenia (Thrombopenia) 04/2005 - 07/2004
1	Critical Illness (Critically Ill) 01/2019
1	Leukoaraiosis 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 08/2018
1	Cerebral Hemorrhage 01/2016
1	Shoulder Fractures 08/2014
1	Varicose Veins (Varicose Vein) 02/2014
1	Lung Neoplasms (Lung Cancer) 05/2012
1	Neoplasm Metastasis (Metastasis) 05/2012
1	Multiple Myeloma 05/2012
1	Disseminated Intravascular Coagulation 07/2011
1	Retinal Vein Occlusion 02/2010
1	Protein C Deficiency 01/2008
1	Wounds and Injuries (Trauma) 01/2007
1	Heart Neoplasms 10/2006
1	Respiratory Insufficiency (Respiratory Failure) 10/2006
1	Obesity 10/2006
1	Thrombophilia 10/2006
1	Leukemia 07/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2004
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2004

Drug/Important Bio-Agent (IBA)

30	AnticoagulantsIBA 12/2020 - 07/2003
11	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019 - 01/2008
8	RivaroxabanIBA 01/2020 - 04/2013
6	Vitamin K FDA Link 01/2020 - 09/2009
6	Heparin (Liquaemin)FDA LinkGeneric 01/2019 - 07/2004
6	Enoxaparin (Lovenox)FDA LinkGeneric 10/2018 - 07/2004
5	Factor Xa InhibitorsIBA 05/2015 - 01/2008
4	Warfarin (Coumadin)FDA LinkGeneric 07/2021 - 01/2016
3	apixabanIBA 01/2020 - 08/2012
3	Pharmaceutical PreparationsIBA 01/2019 - 06/2005
3	parnaparinIBA 02/2014 - 02/2010
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 02/2010
2	fibrin fragment D (D-dimer)IBA 10/2016 - 10/2008
1	Dabigatran FDA Link 01/2020
1	Tinzaparin (Innohep)FDA Link 06/2019
1	N(4)-oleylcytosine arabinosideIBA 10/2018
1	Dalteparin (Dalteparin Sodium)FDA Link 08/2018
1	edoxabanIBA 08/2018
1	Biosimilar PharmaceuticalsIBA 01/2017
1	FluxumIBA 02/2014
1	Risperidone (Risperdal Consta)FDA LinkGeneric 12/2012
1	Factor Xa (Coagulation Factor Xa)IBA 08/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2012
1	Lenalidomide (CC 5013)FDA Link 05/2012
1	Thalidomide (Thalomid)FDA Link 05/2012
1	Factor VIIa (Activated Factor VII)IBA 07/2011
1	Fondaparinux (Arixtra)FDA Link 02/2010
1	factor V LeidenIBA 05/2009
1	Prothrombin (Factor II)IBA 05/2009
1	Protein CIBA 01/2008
1	bemiparinIBA 01/2007
1	ximelagatran (Exanta)IBA 04/2005
1	Thrombin FDA Link 04/2005

Therapy/Procedure

17	Therapeutics 07/2021 - 07/2003
5	Orthopedic Procedures 04/2015 - 04/2005
4	Secondary Prevention 01/2020 - 02/2016
4	Contraindications 05/2012 - 04/2012
4	Catheters 04/2012 - 06/2005
2	Anticoagulation Reversal 01/2017 - 09/2011
2	Knee Replacement Arthroplasty (Total Knee Replacement) 03/2015 - 08/2012
2	Operative Surgical Procedures 08/2014 - 10/2006
2	Bariatric Surgery 02/2014 - 12/2009
2	Drug Therapy (Chemotherapy) 05/2012 - 07/2004
1	Thrombolytic Therapy 01/2020
1	Thrombectomy 01/2020
1	Hemiarthroplasty 08/2014
1	Hip Replacement Arthroplasty (Total Hip Replacement) 08/2012
1	Radiotherapy 05/2012
1	Central Venous Catheters 05/2012
1	Vena Cava Filters (Inferior Vena Cava Filter) 02/2008
1	Duration of Therapy 07/2003